Navigation Links
UH Case Medical Center Offers New Therapy for Gynecologic Cancer Patients
Date:1/20/2012

d HITEC is performed after minimally invasive lung surgery.

A second study is for advanced ovarian cancer patients in remission who have finished initial therapy of surgery and chemotherapy and then undergo HIPEC to prevent recurrence. A third study will involve patients whose cancer recurs and HIPEC is performed following surgical resection of their disease. A fourth is for patients on a neoadjuvant regimen who have had initial chemotherapy and HIPEC is incorporated into their surgery.

There are several advantages to HIPEC compared to traditional chemotherapy, including improved survival rates for gynecologic cancer patients. Previous studies on the use of chemotherapy given directly into the abdomen, known as intraperitoneal (IP) chemotherapy, have shown an extension of women's lives with advanced ovarian cancer on average of 1.5 years longer than women receiving intravenous (IV) treatment.

HIPEC allows a much higher dose of chemotherapy to permeate the diseased tissue. Because conventional chemotherapy is usually administered intravenously, it circulates throughout the body and is diluted by the time it reaches the abdomen. 

"Despite the obvious benefits, only a minority of women currently receive IP therapy due to practical difficulties involved in administering chemo directly in the abdomen following surgery," says Dr. DeBernardo. "HIPEC is now viewed as the next logical step in treating gynecologic cancers such as recurrent and new ovarian and certain endometrial cancers."

Additionally, there has been strong research demonstrating that heating the solution (hyperthermia) also enhances the power of the chemotherapy, improving absorption by tumors and susceptibility of cancer cells. Furthermore, because chemotherapy is kept within the abdomen, HIPEC minimizes the rest of the body's exposure to the treatment, which helps reduce some side effects such as hair loss.

In addition to gynecologic cancer patients, the mult
'/>"/>

SOURCE University Hospitals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. First Choice Rehabilitation Specialists Joins Select Medical
2. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
3. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
4. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
5. Live Press Briefing on Findings of Biomedical Industry CEO Survey
6. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
7. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
8. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
9. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
10. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
11. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... As part of its ongoing efforts to improve ... for patients diagnosed with scoliosis, Axial Biotech, Inc., a ... diagnostic technologies, today announced that it has signed a ... . The agreement focuses on providing ...
... University of Manchester by Professor Andre Geim and Professor Kostya ... is already being used in such varied applications as touch ... are presenting the vast potential of the wonder material at ... (5 July 2010). The display aims to ...
... 5, 2011 Genesis Biopharma, Inc. (OTC/BB: GNBP), ... announced Laszlo Radvanyi, Ph.D., an Associate Professor in ... the University of Texas MD Anderson Cancer Center ... Advisory Board.  MD Anderson is one of the ...
Cached Biology Technology:Axial Biotech Signs Agreement With Shriners Hospital for Children 2Axial Biotech Signs Agreement With Shriners Hospital for Children 3The wonders of graphene on display 2Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board 2Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board 3
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) ... Monitor: North America Perimeter Security Systems Market" report ... The North American perimeter security market ... from 2014 to 2019. Although the U.S. market holds ... is expected to grow at a higher ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and ... the addition of the "Samsung Galaxy S5 ... report to their offering. ... a totally different sensing technology than the iPhone ... fingerprint sensor in its product. The ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader ... PerformTek biometric technology to industry leaders such as Intel, ... clinically validated, biometric wearable products. These products will be ... Las Vegas . ... accurate, flexible and robust – with the clinical data ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... tuberculosis drug may be effective against not only multi drug-resistant ... compound to treat the latent stage of infection as well. ... Biodefense Research Meeting. , "The class of which this compound ... from any other drug currently used to treat tuberculosis. ...
... raged over whether organic compounds and tiny globules of ... 84001 were processed by living creatures from the Red ... scrutiny ever since. Scientists at the Carnegie Institution's Geophysical ... how material associated with carbonate globules was created using ...
... stem cells may be free of the ethical concerns that ... scientific challenges. Chief among these is the doggedness with which ... isolated from the body. This makes it nearly impossible for ... stem cells are so rare, that makes it difficult to ...
Cached Biology News:Experimental TB drug effective against resistant and latent mycobacterium tuberculosis 2Relic of life in that Martian meteorite? A fresh look 2Powerful technique for multiplying adult stem cells may aid therapies 2Powerful technique for multiplying adult stem cells may aid therapies 3
Request Info...
...
... potent inhibition of RNase A-type ribonucleases Product ... of nonhuman origin that binds noncovalently and ... A, B, and C). It does not ... U2, or CL3. QIAGEN RNase Inhibitor inhibits ...
Request Info...
Biology Products: